United Kingdom Respiratory Care Devices Market Insights Forecasts to 2033

• The Market is growing at a CAGR of 9.8% from 2023 to 2033
• The U.K. Respiratory Care Devices Market Size is Expected to Hold a Significant Share by 2033

The United Kingdom Respiratory Care Devices Market is anticipated to hold a significant share by 2033, growing at a CAGR of 9.8% from 2023 to 2033. The growing prevalence of respiratory disorders, technological advancements, and rising application in home care settings are driving the growth of the respiratory care devices market in the United Kingdom.      

Market Overview

Respiratory care devices are medical equipment that includes breathing devices for providing continuous artificial respiration, respiratory diagnostic devices, and therapeutic devices. These are employed in the diagnosis, treatment, control, and assessment of patients with cardiopulmonary disorders. These are used to treat many chronic and acute respiratory illnesses as well as degenerative lung diseases such as asthma, emphysema, and chronic bronchitis. According to the European Respiratory Journal, about 585,000 respiratory diseases are diagnosed annually in the UK, with COPD and asthma accounting for half of these cases. Respiratory diseases rank third in terms of cause of mortality, following cancer and cardiovascular disorders. Modern respiratory devices have completely transformed the way respiratory disorders are treated, improving respiratory health and well-being in general. The market for respiratory care devices could expand in the upcoming years due to the rise in the need for home care therapeutic devices.

Report Coverage

This research report categorizes the market for the UK respiratory care devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the respiratory care devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the respiratory care devices market.

Driving Factors

The increased prevalence of respiratory disorders in the UK is driving the market growth for respiratory care devices. Several major key market players are announcing a number of cutting-edge spirometers for patients in the UK, which results in propelling market growth. The rising applications in home care settings most commonly for patients with chronic obstructive pulmonary disease (COPD) are driving the market.

Restraining Factors

The high cost of respiratory devices is expected to hamper the market growth. Further, the lack of patient compliance with respiratory device therapy due to the lack of affordability and comfort may challenge the market growth.

Market Segmentation

The United Kingdom Respiratory Care Devices Market share is classified into product, disease indication, and end user.

• The therapeutic devices segment dominates the market with the largest market share during the forecast period.

The United Kingdom respiratory care devices market is segmented by product into therapeutic devices, monitoring devices, consumables, and accessories. Among these, the therapeutic devices segment dominates the market with the largest market share during the forecast period. Therapeutic devices are comprised of inhalers, nebulizers, positive airway pressure machines, and oxygen concentrators. The increasing incidence of respiratory ailments in UK as well as the technological advancements are driving the market.

• The chronic obstructive pulmonary disease (COPD) segment is expected to grow at the fastest CAGR during the forecast period.

Based on the disease indication, the United Kingdom respiratory care devices market is divided into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Among these, the chronic obstructive pulmonary disease (COPD)segment is expected to grow at the fastest CAGR during the forecast period. COPD affects millions of individuals in the UK, managed by medications like bronchodilators, corticosteroids, and combination therapy. The rising prevalence of COPD due to increasing air pollution levels and exposure to dust and chemicals are driving up the market demand.

• The home care settings segment is anticipated to grow at the fastest CAGR during the forecast period.       

Based on the end user, the United Kingdom respiratory care devices market is divided into hospitals, home care settings, ambulatory care centers (ACCs), and others. Among these, the home care settings segment is anticipated to grow at the fastest CAGR during the forecast period. Home care settings are cost-effective as they reduce long-term care expenses and reduce hospital readmissions. The rising application of positive airway pressure devices for sleep apnea therapy is significantly responsible for driving the market growth in the home care settings segment.        

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the UK respiratory care devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• DeVilbiss Healthcare LLC
• Dragerwerk AG
• GE Healthcare
• Fisher & Paykel Healthcare Ltd
• GlaxoSmithKline PLC
• Koninklijke Philips NV
• Medtronic PLC
• Invacare Corporation
• ResMed Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2022, Honeywell announced two new NIOSH-certified respiratory offerings to help meet the needs of healthcare workers. The new products expand Honeywell’s personal protective equipment (PPE) portfolio for healthcare professionals, incorporating the company’s decades of expertise in producing respiratory-protection solutions.
• In January 2022, Oxygen equipment maker Responsive Respiratory released a new Product Solutions catalog to provide a resource guide for the home healthcare, hospital and EMS markets.

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United Kingdom Respiratory Care Devices Market based on the below-mentioned segments:

United Kingdom Respiratory Care Devices Market, By Product

• Therapeutic Devices
• Monitoring Devices
• Consumables
• Accessories

United Kingdom Respiratory Care Devices Market, By Disease Indication

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea, Asthma
• Infectious Diseases
• Others

United Kingdom Respiratory Care Devices Market, By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Centers (ACCs)
• Others